Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 19, 2024
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline UpdateJohn D Gordan, Erin B Kennedy, Ghassan K Abou-Alfa, et al.
Oncoimmunology|November 15, 2021
Implantation of a neoantigen-targeted hydrogel vaccine prevents recurrence of pancreatic adenocarcinoma after incomplete resectionDaniel Delitto, Daniel J Zabransky, Fangluo Chen, et al.
Cancer Immunology Research|June 26, 2026
Peripheral Th17 immune signature associates with excellent response to anti-PD1/anti-PD-L1 therapy across solid tumorsHoward L Li, Soren Charmsaz, Chester Kao, et al.
Journal of Hepatology|November 8, 2025
DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCCZeal Kamdar, Ethan Neumann, Kathryn Howe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 30, 2026
A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without cobimetinib in previously-treated unresectable biliary tract cancerThatcher Ross Heumann, Jiayun Lu, Hao Wang, et al.
Nature Cancer|November 19, 2021
Neoadjuvant Cabozantinib and Nivolumab Converts Locally Advanced HCC into Resectable Disease with Enhanced Antitumor ImmunityWon Jin Ho, Qingfeng Zhu, Jennifer Durham, et al.
Journal for Immunotherapy of Cancer|April 21, 2026
Time-of-day of first checkpoint inhibitor dose influences clinical outcomes and immune responses in hepatocellular carcinomaHoward L Li, Soren Charmsaz, Benjamin J Reisman, et al.
Cancer Immunology Research|August 15, 2025
Neoadjuvant immunotherapy promotes the formation of mature tertiary lymphoid structures in a remodeled pancreatic tumor microenvironmentDimitrios N Sidiropoulos, Sarah M Shin, Meredith Wetzel, et al.
Nature Medicine|November 25, 2025
A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trialMarina Baretti, Allison M Kirk, Brian H Ladle, et al.
Nature Communications|April 21, 2025
Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitorsChester Kao, Soren Charmsaz, Hua-Ling Tsai, et al.
Pageof 14